Imlygic Եվրոպական Միություն - սլովեներեն - EMA (European Medicines Agency)

imlygic

amgen europe b.v. - talimogene laherparepvec - melanoma - antineoplastična sredstva - imlygic je indicirano za zdravljenje odraslih z neoperabilnim melanom, ki je regionalno ali daljno metastatskim (faza iiib, iiic in ivm1a), brez kosti, možganov, pljuč ali drugih visceralno bolezni.

Tecartus Եվրոպական Միություն - սլովեներեն - EMA (European Medicines Agency)

tecartus

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - limfom, mantle cell - antineoplastična sredstva - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).